Xact Kapitalforvaltning’s Pacira BioSciences PCRX Stock Holding History

Xact Kapitalforvaltning’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$229K	Hold	6,823	–	–	﹤0.01%	1151
2019 Q4	$309K	Hold	6,823	–	–	0.01%	1229
2019 Q3	$260K	Hold	6,823	–	–	﹤0.01%	1271
2019 Q2	$297K	Hold	6,823	–	–	0.01%	1233
2019 Q1	$260K	Hold	6,823	–	–	0.01%	1295
2018 Q4	$294K	Hold	6,823	–	–	0.01%	1240
2018 Q3	$335K	Hold	6,823	–	–	0.01%	1286
2018 Q2	$219K	Buy	+6,823	New	+$236K	﹤0.01%	1512

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Xact Kapitalforvaltning's PCRX Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Pacira BioSciences (PCRX) position steady in Q1 2020 at 6,823 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Xact Kapitalforvaltning first reported a position in PCRX in Q2 2018 and has held it in 8 quarters since. The position peaked at $335K in Q3 2018. 226 funds tracked by Wall St. Rank hold PCRX as of Q1 2020.

Xact Kapitalforvaltning held 6,823 shares of Pacira BioSciences worth $229K as of Q1 2020.
Xact Kapitalforvaltning left its Pacira BioSciences share count unchanged in Q1 2020.
Pacira BioSciences made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1151 holding.
Xact Kapitalforvaltning first reported a position in Pacira BioSciences in Q2 2018 and has held it in 8 quarters since.
Xact Kapitalforvaltning's Pacira BioSciences position peaked at $335K in Q3 2018.
226 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.